{"id":10048,"date":"2026-09-23T14:24:04","date_gmt":"2026-09-23T14:24:04","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/filovirus-collaborative-open-research-consortium-research-priorities-for-the-ongoing-bundibugyo-virus-disease-outbreak\/"},"modified":"2026-09-23T14:24:04","modified_gmt":"2026-09-23T14:24:04","slug":"filovirus-collaborative-open-research-consortium-research-priorities-for-the-ongoing-bundibugyo-virus-disease-outbreak","status":"publish","type":"ground_post","link":"https:\/\/godshand.link\/en_gb\/ground_post\/filovirus-collaborative-open-research-consortium-research-priorities-for-the-ongoing-bundibugyo-virus-disease-outbreak\/","title":{"rendered":"Filovirus collaborative open research consortium research priorities for the ongoing Bundibugyo virus disease outbreak"},"content":{"rendered":"<p><br \/>\n<\/p>\n<section class=\"dynamic-content__section dynamic-content__container\">\n<div class=\"dynamic-content__section-container\">\n<div class=\"dynamic-content__figure-container\">\n<figure class=\"dynamic-content__figure\">\n      <img decoding=\"async\" src=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/bdd359a6-4b69-43a9-b24b-36fbb650a8ea\/content\" alt=\"Filovirus collaborative open research consortium research priorities for the ongoing Bundibugyo virus disease outbreak\"><br \/>\n     <\/figure>\n<div class=\"button button-blue-background\"><a target=\"_blank\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/2ca5ef8f-d3cf-408b-8838-744dd6baeaf0\/content\" onclick=\"sendGaEvent('Download','https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/2ca5ef8f-d3cf-408b-8838-744dd6baeaf0\/content')\">Download <span>(409.3 kB)<\/span><\/a><\/div><\/div>\n<div class=\"dynamic-content__description-container\">\n<div class=\"row\">\n<div class=\"col-md-8\">\n<div class=\"dynamic-content__description\">\n<h3>Overview <\/h3>\n<p>Bundibugyo virus remains one of the least studied <em>Orthoebolaviruses<\/em> with no licensed vaccine or treatment. This document sets out ten research priorities developed through the WHO research and development blueprint for epidemics, building on the filovirus collaborative open research consortium roadmap and in collaboration with international partners, to accelerate evidence generation during the ongoing Bundibugyo virus disease outbreak. <\/p>\n<p>It covers disease characterization, community engagement, diagnostics, clinical management, therapeutics, vaccines and post-exposure prophylaxis, and outlines an implementation framework across the immediate, ongoing and post-outbreak phases.<\/p>\n<\/p><\/div><\/div>\n<div class=\"col-md-4\">\n<div class=\"dynamic-content__details\">\n<div class=\"detail who-team\">\n<div class=\"label\">WHO Team<\/div>\n<div class=\"value\">\n                 <span><br \/>\nChief Scientist and Science Division (SCI)                 <\/span>\n         <\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Editors<\/div>\n<div class=\"value\">World Health Organization<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Number of pages<\/div>\n<div class=\"value\">11<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Reference numbers<\/div>\n<div class=\"value\">\n<div><strong class=\"label-sm\">WHO Reference Number: <\/strong><span>B09906<\/span><\/div><\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Copyright<\/div>\n<p>                <a target=\"_blank\" class=\"creativecommons-icons-wrappers\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo\/deed.en\" rel=\"license\" title=\"Click here to see the details of CC BY-NC-SA 3.0 IGO\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/cc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/by.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/nc.svg\"><br \/>\n                        <img decoding=\"async\" src=\"https:\/\/www.who.int\/ResourcePackages\/WHO\/assets\/icons\/cc-icons\/sa.svg\"><br \/>\n                <\/a>\n        <\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.who.int\/publications\/i\/item\/B09906?rand=6398\" target=\"_blank\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Download (409.3 kB) Overview Bundibugyo virus remains one of the least studied Orthoebolaviruses with no licensed vaccine or treatment. This document sets out ten research priorities developed through the WHO research and development blueprint for epidemics, building on the filovirus collaborative open research consortium roadmap and in collaboration with international partners, to accelerate evidence generation during the ongoing Bundibugyo virus&hellip;<\/p>","protected":false},"author":99035,"featured_media":10049,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[2590,1788,3373,1898,2735,1821,3372,2084,2118,1250,2508],"ground_category":[315,316],"class_list":["post-10048","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-bundibugyo","tag-collaborative","tag-consortium","tag-disease","tag-filovirus","tag-ongoing","tag-open","tag-outbreak","tag-priorities","tag-research","tag-virus","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/bdd359a6-4b69-43a9-b24b-36fbb650a8ea\/content","_links":{"self":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/10048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=10048"}],"version-history":[{"count":0,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/10048\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/10049"}],"wp:attachment":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=10048"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=10048"},{"taxonomy":"ground_category","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=10048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}